Double Bottom?Is Curaleaf going to shake off the FUD from the FDA & continue crush the U.S market.
I think so, although they may have stepped over some boundaries with promotion / labeling & making claims on some of their cbd products, it doesn't change the position they have in the U.S with distribution.
It looks like CURA may have found a double bottom?
Time will tell per usual.
Healthcarestocks
#IMMU look at Risk vs. Reward #VolatilitywatchThis trade brings opportunity for investors looking for a a company with great fundamentals and nice risk/reward potential into end of year. As the chart shows (blue arrows) I am awaiting a buying opp around the blue trend line.
From current stock price, potential risk/reward around 3.5 : 1
downside risk: $1.39
upside reward: $3.50-$5
Recent selloff after earnings showed strong support at the $11.59 level, which also made a double bottom.
This selloff started around July, 2018. to emphasize the double bottom even more, the pullback from peak to trough retraced .618; a key level of Fibonacci support.
MACD indicator showing strong convergence with price
Price above 20 day moving average.
5-day exponential moving average above 20 day moving average, indicating strength in trend.
Conclusion: $IMMU seems to bring opportunistic risk/ reward to investors who are sidelined. Double bottoms are significant patterns when looking for price reversal.
Tip # 11: Some investors wait to buy until after stock price crosses above moving averages such as the 20, 50, 100, and 200 day. These are key phycological levels to watch when trading and investing.
Like and follow so I can continue giving trend analysis and trade ideas. Thank you in advance =)
Follow me on twitter or Instagram @Volatilitywatch
Disclosure: I do not own IMMU. This is not a note to buy or sell. Please do your homework before investing.
Double Bottom?The double bottom pattern always follows a major or minor downtrend in a particular security, and signals the reversal and the beginning of a potential uptrend.
Time will tell per usual.
Has Aleafia found a bottom?Aleafia is looking to retest a recent support that was made May 3rd.
If it holds then we will see a double bottom & possibly a reverse in the trend after the break through the descending triangle I spoke about in my previous post.
$JSENTC Netcare 911, we have an emergency!This chart looks like an emergency that requires an urgent intervention! Perhaps the major volume seen today could be an indication of capitulation and i will be monitoring the price action in the days ahead to see if it is able to recover from these over extended levels. Should this level hold which is also coincidentally the bottom of the downward sloping channel, we could see a bounce take place to the R21.00 - R21.60 area. R21.60 is an area where the chart also has a small gap which might want to fill first before any further downside ensues.
ISRG: Topping Formation Risk for Selling Short PotentialIntuitive Surgical Inc., under the Medical Instruments and Supplies industry, has had strong growth over the past 3 years but it is now facing the risk of a topping formation. The topping pattern is near the phase where a completed top could occur and then downside action would include sell short professionals and sell short HFTs. Support doesn’t kick in strongly until the stock reaches the 240-250 area, which is below the 50% loss of most companies thus far in the bear market. Many firms have already lost 50% or more off their all-time high values. ISRG can shift sideways and stay there to pattern out the excessive speculation, but the technical pattern is setting up more like a risk of a top formation at this moment in time.
PFE bullish signalPFE shares show unusual buying. This should help the stock continue its bullish move higher.
MRK breaks out to new 52-week highs quietlyThe Health Care sector has been showing very nice breadth. MRK remains a leader in this tape.
BIOTECH bouncing back!!A choppy market since the February market turmoil, but I think we are back on track. Longterm we are still locked in a bullish play, and I think we may have completed a 4thwave play on the internal wave count and are now making moves to shape up the final 5th-wave.
Here is the longterm view so far:
A Low Beta Way to Play Biopharma IndustryAttached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes liquidation / bankruptcy. Give it a read and let me know what y'all think.
rockvuecapital.wordpress.com
All the best,
RC
